Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Apellis Pharmaceuticals Q4 EPS $(1.50) Beats $(1.57) Estimate

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.57) by 4.46 percent. This is a 6.83 percent increase over losses of $(1.61) per share
byBill Haddad
February 21, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Apellis Pharmaceuticals (NASDAQ:APLS) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.57) by 4.46 percent. This is a 6.83 percent increase over losses of $(1.61) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts